Author: OurCrowd

[Freightos in PR Newswire] United Cargo Adds Capacity to WebCargo by Freightos’ Booking Platform, Extending Cargo Sales Portal Capabilities

May 16, 2024 |

BARCELONA, Spain, May 16, 2024 /PRNewswire/ — Freightos (NASDAQ: CRGO), the vendor-neutral booking and payment platform for the international freight industry, is pleased to expand the collaboration between WebCargo by Freightos and United Cargo (NASDAQ: UAL). In an industry which is still mostly offline, WebCargo is proud to be a key technology partner developing United Cargo’s state-of-the-art self-service online cargo portal and is proud to further expand this collaboration. Read...

Read More

[BrainQ in Startup News] Results from BRAIN.Q’s EMAGINE study on the use of AI-powered electromagnetic field therapy offer hope for meaningful recovery following stroke

May 16, 2024 |

BRAIN.Q, an emerging leader in AI-driven Brain Longevity Therapeutics today announced promising results from its U.S. multicenter randomized controlled study – EMAGINE, suggesting that treatment with its AI-powered electromagnetic field therapy may lead to meaningful clinical benefits and a substantial reduction in disability following a stroke. These promising results align with the encouraging findings observed in an earlier randomized controlled pilot trial done with BRAIN.Q’s therapy, announced in 2021. Read more...

Read More

[CytoReason in Startup News] Using AI-models to find curse for diseaseCytoReason and the Crohn’s & Colitis Foundation forge groundbreaking data collaboration to advance IBD research[CytoReason in NoCamels] Using AI-models to find curse for disease

May 16, 2024 |

CytoReason, a pioneer in developing computational disease for drug development, today announced a strategic collaboration with the Crohn’s & Colitis Foundation. The collaboration aims to empower CytoReason’s analytical capabilities with the Foundation’s IBD Plexus® real-world data platform. This collaboration has the potential to accelerate new discoveries with superior data integration and improve the precision and effectiveness of drug development in inflammatory bowel disease (IBD). Read...

Read More

[IQM in Qauntum Insider] IQM Quantum Computers Collaborates With Hewlett Packard Enterprise And Demonstrates Quantum-HPC Integration

May 15, 2024 |

PRESS RELEASE — IQM Quantum Computers (IQM), a global leader in building quantum computers, announced a collaboration and showcase of a joint demo of quantum computing and high-performance computing (HPC) integration at ISC High Performance 2024, the annual international supercomputing conference in Hamburg, with Hewlett Packard Enterprise (HPE), the global edge-to-cloud company. Read...

Read More